Summary
In-stent restenosis occurs in about 54% to 59% of cases and is the primary location of restenosis in the access circuit. Yet there is no evidence-based recommendation for the treatment of in-stent restenosis. This article discusses data from the FLUENCY PLUS Endovascular Stent Graft for In-stent Restenosis trial [RESCUE; NCT01257438].
- Nephrology Clinical Trials
- Coronary Artery Disease
- Interventional Radiology
- Interventional Techniques & Devices
- Renal Artery Obstruction
- Nephrology Clinical Trials
- Coronary Artery Disease
- Interventional Radiology
- Interventional Techniques & Devices
- Renal Artery Obstruction
- Nephrology
- © 2015 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.